Related Experiment Video
Updated: Jun 22, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A
David F Gardiner1, Talia Rosenberg, Jerry Zaharatos
1Division of International Medicine and Infectious Diseases, Weill Cornell Medical College, New York, NY, United States. DFGardiner@gmail.com
Abstract:
Clostridium difficile is a pathogen with increasing severity for which host antibody responses provide protection from disease. DNA vaccination has several advantages compared to traditional vaccine methods, however no study has examined this platform against C. difficile toxins. A synthetic gene was created encoding the receptor-binding domain (RBD) of C. difficile toxin A, optimized for expression in human cells. Gene expression was examined in vitro. Mice were inoculated and then challenged with parenteral toxin A. Vaccination provided high titer antibodies and protected mice from death. This represents the first report of DNA vaccine inducing neutralizing antibodies to C. difficile toxin A.
More Related Videos
Related Concept Videos
Diphtheria
Bacterial Toxins
Botulism
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
DNA Bacteriophages
Tetanus

